event
The Alumni Association of KAIST hosted the first KAIST Technology Exchange Meeting on September 12th at the KAIST Institute on campus.
About 14 alumni companies, MDS Technology, Biospace, and Satrec Initiative, two private equity funds including KAIST Entrepreneurship Foundation, and KAIST Technology Commercialization Center participated in this meeting.
This meeting was organized by the Alumni Association of KAIST in order to strengthen cooperation between alumni companies and KAIST members by increasing technology exchange and fostering cooperative culture.
The meeting comprised of two sessions: product exhibition and technology-exchange session.
During the exhibition, participating companies prepared the following: product showcase, intellectual property exchange, project consulting, and employment information.
Companies involved in technology-exchange session not only showcased their brand new technology but also shared their innovative ideas and entrepreneur vision, and discussed joint R&D.
The president of the Alumni Association of KAIST, Man Kee Baek who was in charge of this meeting said, “I hope this meeting stimulates more technology exchange between alumni companies and school members.”
He added that “our alumni association will continue to organize many projects for better KAIST.”
Detailed information about the event can be found on the official webpage of the Alumni Association of KAIST (http://www.ilovekaist.net), and this event was open to the public.
A company specializing in medical devices, Biospace, plans to donate a body composition analyzer and an automatic blood pressure meter worth 14,000,000 won to KAIST.
-
research Revolutionary 'scLENS' Unveiled to Decode Complex Single-Cell Genomic Data
Unlocking biological information from complex single-cell genomic data has just become easier and more precise, thanks to the innovative 'scLENS' tool developed by the Biomedical Mathematics Group within the IBS Center for Mathematical and Computational Sciences led by Chief Investigator Jae Kyoung Kim, who is also a professor at KAIST. This new finding represents a significant leap forward in the field of single-cell transcriptomics. Single-cell genomic analysis is an advanced technique that m
2024-05-09 -
research KAIST Develops Sodium Battery Capable of Rapid Charging in Just a Few Seconds
Sodium (Na), which is over 500 times more abundant than lithium (Li), has recently garnered significant attention for its potential in sodium-ion battery technologies. However, existing sodium-ion batteries face fundamental limitations, including lower power output, constrained storage properties, and longer charging times, necessitating the development of next-generation energy storage materials. On the 11th of April, KAIST (represented by President Kwang Hyung Lee) announced that a research t
2024-04-18 -
research KAIST introduces microbial food as a strategy food production of the future
The global food crisis is increasing due to rapid population growth and declining food productivity to climate change. Moreover, today's food production and supply system emit a huge amount of carbon dioxide, reaching 30% of the total amount emitted by humanity, aggravating climate change. Sustainable and nutritious microbial food is attracting attention as a key to overcoming this impasse. KAIST (President Kwang Hyung Lee) announced on April 12th that Research Professor Kyeong Rok Choi of th
2024-04-12 -
research KAIST researchers developed a novel ultra-low power memory for neuromorphic computing
A team of Korean researchers is making headlines by developing a new memory device that can be used to replace existing memory or used in implementing neuromorphic computing for next-generation artificial intelligence hardware for its low processing costs and its ultra-low power consumption. KAIST (President Kwang-Hyung Lee) announced on April 4th that Professor Shinhyun Choi's research team in the School of Electrical Engineering has developed a next-generation phase change memory* device fe
2024-04-04 -
research A KAIST-SNUH Team Devises a Way to Make Mathematical Predictions to find Metabolites Related to Somatic Mutations in Cancers
Cancer is characterized by abnormal metabolic processes different from those of normal cells. Therefore, cancer metabolism has been extensively studied to develop effective diagnosis and treatment strategies. Notable achievements of cancer metabolism studies include the discovery of oncometabolites* and the approval of anticancer drugs by the U.S. Food and Drug Administration (FDA) that target enzymes associated with oncometabolites. Approved anticancer drugs such as ‘Tibsovo (active ingre
2024-03-18